Pier Vincenzo Piazza

French biotech company Aelis Farma, specializing in the treatment of brain disorders announced positive results Monday from a Phase 1/2 trial of its drug candidate AEF0217 in young adults with Down syndrome. The study, conducted in Spain, assessed the safety, tolerability and potential efficacy of...

With more and more states and countries embracing cannabis whether for medical or recreational purposes, it could be assumed that the number of people dependent on it would also increase. Even now, the Centers for Disease Control and Prevention warns that estimates show every 3 in 10 people...